Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Medipharm Labs Corp
(TSX:
LABS
)
0.0700
+0.0050 (+7.69%)
Streaming Delayed Price
Updated: 9:37 AM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Medipharm Labs Corp
< Previous
1
2
Next >
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience
December 19, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns
December 10, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Labs Completes First Shipment to France
December 04, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law
November 14, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains
November 13, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
November 10, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
August 14, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
August 11, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler
July 24, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
June 17, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
June 16, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
Apollo Capital Wins Proxy Contest at MediPharm Labs
June 16, 2025
From
Apollo Technology Capital Corporation
Via
GlobeNewswire
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
June 13, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
June 11, 2025
Shareholders Urged to Vote for Proven Strategy and Team, Reject Dissident’s Inadequate Plan and Nominees
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
June 11, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World’s Leading International Medical Cannabis Company
June 11, 2025
From
Apollo Technology Capital Corporation
Via
GlobeNewswire
This Week In Cannabis: America's Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago
↗
June 06, 2025
Congress advances hemp THC ban as cannabis leaders prep for Benzinga's Chicago conference. Global markets shift. Here's the full recap.
Via
Benzinga
Topics
Cannabis
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
June 05, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apollo’s Arguments and Director Slate
June 02, 2025
ISS concludes that Apollo “has not presented a compelling case for change”
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Labs Refuses to Answer Direct Questions Regarding Credible Securities Fraud Allegations Says Apollo Capital
May 30, 2025
From
Apollo Technology Capital Corporation
Via
GlobeNewswire
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
May 29, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
Alleged Securities Fraud at MediPharm Labs Says Apollo Capital
May 29, 2025
From
Apollo Technology Capital Corporation
Via
GlobeNewswire
MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan
May 28, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
Apollo Capital Calls Out MediPharm Chairman Chris Taves (Managing Director, BMO Capital Markets) for Failure to Properly Communicate to Shareholders Details of David Pidduck’s Past as CEO and VP of Marketing for OxyContin® Manufacturer Purdue Pharma
May 27, 2025
From
Apollo Technology Capital Corporation
Via
GlobeNewswire
MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United Kingdom Under Blackpoint Sales and Distribution Agreement
May 26, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.
May 23, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
Apollo Capital Comments on MediPharm Labs’ Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual Meeting
May 23, 2025
From
Apollo Technology Capital Corporation
Via
GlobeNewswire
MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June
May 22, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings
May 21, 2025
From
MediPharm Labs Corp.
Via
GlobeNewswire
CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth
↗
November 14, 2024
CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third quarter financial results for the three months ended Sept. 30, 2024."Q3 2024...
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
